Webinars - Neurology
Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration
neurobiology of disease | October 25, 2019
Höglund K, Schussler N, Kvartsberg H, Smailovic U, Brinkmalm G, Liman V, Becker B, Zetterberg H, Cedazo-Minguez A, Janelidze S, Lefevre IA, Eyquem S, Hansson O and Blennow K. Neurobiol Dis. 2019 Oct 25;134:104645.
Jessica Gill, PhD, RN, from the National Institute of Health, presented her research on the role of proteomic biomarkers of brain injuries at the inaugural Powering Precision Health Summit 2016.
TBIs are common in military personnel and civilians, placing these individuals at high risk for neurological deficits. The reasons why some individuals are at higher risk for these symptoms and deficits remains largely unknown. This webinar explores the topic further.
Biomarkers for Precision Health: Enabling applications for neurological disease detection and monitoring
June 28, 2017
Join our CEO Kevin Hrusovsky, Dr. Jessica Gill (NIH) and Dr. Henrik Zetterberg (University of Gothenburg) as they discuss how Simoa Technology uses ultrasensitive biomarker assays to enable precision health with case studies in neurodegeneration and neurotrauma.
Danielle Graham, PhD from Biogen presented on accelerating exploratory fluid biomarker assay development in neurodegenerative disease at the inaugural Powering Precision Health Summit 2016.
Cheryl Wellington, PhD from the University of British Columbia, presented on the functional modeling of the human cerebrovasculature at the inaugural Powering Precision Health Summit 2016.